Page last updated: 2024-08-23

mifepristone and Adverse Drug Event

mifepristone has been researched along with Adverse Drug Event in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (27.27)	18.2507
2000's	2 (18.18)	29.6817
2010's	6 (54.55)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Beal, MW; Eagen-Torkko, MK; Simmonds, KE	1
Chen, M; Hua, Y; Jiang, W; Shen, Q; Zhang, W; Zhu, X	1
Kushner, H; Nguyen, D; Williams, G; Yuen, KC	1
Carmichael, JD; Fleseriu, M	1
Banks, M; Cacace, A; Connors, D; Dickinson, K; Herbst, J; Marino, A; O'Connell, J; Puglisi, J; Sinz, M; Stewart, J; Zhu, Z	1
Potts, M	1
Nathanson, B	1
Nathanson, BN	1

Reviews

2 review(s) available for mifepristone and Adverse Drug Event

Article	Year
Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis. Fertility and sterility, 2013, Volume: 100, Issue:6 Topics: Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Humans; Incidence; Leiomyoma; Mifepristone; Premenopause; Risk Factors; Treatment Outcome; Uterine Neoplasms	2013
Mifepristone: is there a place in the treatment of Cushing's disease? Endocrine, 2013, Volume: 44, Issue:1 Topics: Adrenal Glands; Animals; Drug Delivery Systems; Drug-Related Side Effects and Adverse Reactions; Hormone Antagonists; Humans; Mifepristone; Pituitary ACTH Hypersecretion	2013

Trials

1 trial(s) available for mifepristone and Adverse Drug Event

Article	Year
ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015, Volume: 21, Issue:10 Topics: Adult; Cushing Syndrome; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mifepristone; Receptors, Glucocorticoid; Retrospective Studies; Time Factors; Treatment Outcome	2015

Article

Year

ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015, Volume: 21, Issue:10

Topics: Adult; Cushing Syndrome; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mifepristone; Receptors, Glucocorticoid; Retrospective Studies; Time Factors; Treatment Outcome

2015

Other Studies

8 other study(ies) available for mifepristone and Adverse Drug Event

Article	Year
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion. Journal of midwifery & women's health, 2017, Volume: 62, Issue:3 Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Drug and Narcotic Control; Drug Labeling; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Government Regulation; Health Personnel; Humans; Midwifery; Mifepristone; Misoprostol; Nurse Midwives; Nurse Practitioners; Physician Assistants; Pregnancy; Professional Practice; United States; United States Food and Drug Administration	2017
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay. Journal of biomolecular screening, 2007, Volume: 12, Issue:2 Topics: Biological Assay; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane Permeability; Cryopreservation; Drug-Related Side Effects and Adverse Reactions; Humans; Liver Neoplasms; Mifepristone; Pharmaceutical Preparations; Pregnane X Receptor; Receptors, Steroid; Reproducibility of Results; Rifampin; Sulfinpyrazone; Transcriptional Activation; Transfection	2007
Non-surgical abortion: who's for methotrexate? Lancet (London, England), 1995, Sep-09, Volume: 346, Issue:8976 Topics: Abortifacient Agents; Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Federal Government; Female; Government; Government Regulation; Human Experimentation; Humans; Methods; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Professional Competence; Risk; Risk Assessment; Social Control, Formal; United Kingdom; United States; United States Food and Drug Administration	1995
Licensed to pill. National review, 1992, Feb-03, Volume: 44, Issue:2 Topics: Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; France; Human Experimentation; Humans; International Cooperation; Internationality; Mifepristone; Patient Care; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Risk; Risk Assessment	1992
The abortion cocktail. First things (New York, N.Y.), 1996, Volume: 59 Topics: Abortion, Induced; Drug-Related Side Effects and Adverse Reactions; Ethics Committees; Ethics Committees, Research; Federal Government; Government; Government Regulation; Human Experimentation; Humans; Methotrexate; Mifepristone; Misoprostol; Pharmaceutical Preparations; Pregnancy; Pregnant Women; Research Design; Research Personnel; Risk; Risk Assessment; Scientific Misconduct; Social Control, Formal	1996